Wachtell and Skadden lead Pfizer/Array deal
Pfizer has announced that it will purchase Colorado-based Array Pharmaceuticals in an $11 billion acquisition that adds to Pfizer’s cancer treatment portfolio.
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10